talabostat combined with pembrolizumab in men with mcrpc
Published 2 years ago • 50 plays • Length 3:51Download video MP4
Download video MP3
Similar videos
-
1:05
combining a dna vaccine with pembrolizumab for mcrpc
-
1:21
keynote-921: pembrolizumab plus docetaxel in chemotherapy-naïve mcrpc
-
2:54
updated analysis of keynote-199: pembrolizumab for mcrpc previously treated with docetaxel
-
3:18
keynote-199: an update on pembrolizumab for mcrpc
-
0:58
sabizabulin in men with mcrpc who progressed on an androgen receptor targeting agent
-
0:40
psma pet findings in 225ac-j591-treated patients with mcrpc
-
5:59
apalutamide in combination with abiraterone acetate, docetaxel and prednisone for mcrpc
-
1:17
prince: 177lu-psma-617 and pembrolizumab in prostate cancer
-
0:33
circulating tumor cells in management of patients with castration-resistant prostate cancer
-
3:03
vision: tolerability of 177lu-psma-617 by treatment exposure in patients with mcrpc
-
10:01
evaluating the prognostic value of psma pet/ct in mcrpc
-
2:48
assessing parp inhibition and brca1/2 as a prognostic biomarker in mcrpc
-
1:34
investigating the treatment of unselected mcrpc patients with a cdk 4/6 inhibitor plus abemaciclib
-
6:41
esmo expert report on combination therapy in advanced prostate cancer @ asco gu 2022
-
0:39
stereotactic body rt in patients with oligometastatic crpc undergoing 1l treatment with abiraterone
-
2:10
radium-223 in men with bone mcrpc
-
2:34
first-line treatments for patients with mhspc and mcrpc
-
1:22
cabazitaxel improves rpfs in patients with mcrpc
-
1:38
177lu-psma i&t for patients with psma-positive mcrpc